---
title: Myeloma and DNA damage
date: '2023-11-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37992215/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231123170941&v=2.17.9.post6+86293ac
source: Blood
description: DNA damaging agents have represented the first effective treatment for
  the blood cancer multiple myeloma, and after 65 years since their introduction in
  the clinic, they remain one of the mainstay therapies for this disease. Myeloma
  is a cancer of plasma cells. Despite exceedingly slow proliferation, myeloma cells
  present extended genomic rearrangements and intense genomic instability, starting
  at the premalignant stage of the disease. Where does such DNA damage stem from?
  A reliable ...
disable_comments: true
---
DNA damaging agents have represented the first effective treatment for the blood cancer multiple myeloma, and after 65 years since their introduction in the clinic, they remain one of the mainstay therapies for this disease. Myeloma is a cancer of plasma cells. Despite exceedingly slow proliferation, myeloma cells present extended genomic rearrangements and intense genomic instability, starting at the premalignant stage of the disease. Where does such DNA damage stem from? A reliable ...